| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |